tiprankstipranks
Trending News
More News >
Northrop Grumman (NOC)
NYSE:NOC

Northrop Grumman (NOC) AI Stock Analysis

Compare
4,732 Followers

Top Page

NOC

Northrop Grumman

(NYSE:NOC)

Select Model
Select Model
Select Model
Outperform 76 (OpenAI - 4o)
Rating:76Outperform
Price Target:
$626.00
▲(10.12% Upside)
Northrop Grumman's overall stock score reflects strong financial performance and a positive earnings outlook, driven by robust international growth and strategic investments. However, technical indicators suggest bearish momentum, and valuation metrics indicate the stock is fairly valued. Concerns about revenue guidance revisions and potential impacts from government shutdowns are notable risks.
Positive Factors
Strong Cash Flow Generation
The significant increase in free cash flow indicates strong operational performance and enhances the company's ability to invest in growth opportunities and return capital to shareholders.
International Growth
Robust international growth expands Northrop Grumman's market presence and diversifies revenue streams, reducing reliance on domestic contracts and enhancing long-term stability.
New Contract Award
Securing new contracts strengthens Northrop Grumman's revenue base and demonstrates its competitive edge in securing government contracts, supporting sustained business growth.
Negative Factors
Revenue Guidance Revision
The revision of revenue guidance suggests potential challenges in meeting financial targets, which could affect investor confidence and long-term financial planning.
Space Segment Challenges
Challenges in the space segment may hinder growth prospects in a key area, impacting overall revenue and profitability if not addressed with new opportunities.
Impact of U.S. Government Shutdown
A prolonged government shutdown could disrupt cash flows and contract awards, posing risks to financial stability and operational continuity.

Northrop Grumman (NOC) vs. SPDR S&P 500 ETF (SPY)

Northrop Grumman Business Overview & Revenue Model

Company DescriptionNorthrop Grumman Corporation operates as an aerospace and defense company worldwide. The company's Aeronautics Systems segment designs, develops, manufactures, integrates, and sustains aircraft systems. This segment also offers unmanned autonomous aircraft systems, including high-altitude long-endurance strategic ISR systems and vertical take-off and landing tactical ISR systems; and strategic long-range strike aircraft, tactical fighter and air dominance aircraft, and airborne battle management and command and control systems. Its Defense Systems segment designs, develops, and produces weapons and mission systems. It offers products and services, such as integrated battle management systems, weapons systems and aircraft, and mission systems. This segment also provides command and control and weapons systems, including munitions and missiles; precision strike weapons; propulsion, such as air-breathing and hypersonic systems; gun systems and precision munitions; life cycle service and support for software, weapons systems, and aircraft; and logistics support, sustainment, operation, and modernization for air, sea, and ground systems. The company's Mission Systems segment offers cyber, command, control, communications and computers, intelligence, surveillance, and reconnaissance systems; radar, electro-optical/infrared and acoustic sensors; electronic warfare systems; advanced communications and network systems; cyber solutions; intelligence processing systems; navigation; and maritime power, propulsion, and payload launch systems. This segment also provides airborne multifunction sensors; maritime/land systems and sensors; navigation, targeting, and survivability solutions; and networked information solutions. Its Space Systems segment offers satellites and payloads; ground systems; missile defense systems and interceptors; launch vehicles and related propulsion systems; and strategic missiles. The company was founded in 1939 and is based in Falls Church, Virginia.
How the Company Makes MoneyNorthrop Grumman generates revenue primarily through government contracts, which account for a significant portion of its earnings. The company's revenue model is based on the provision of products, systems, and services that are often long-term contracts with various U.S. government agencies and allied foreign governments. Key revenue streams include defense and aerospace systems, cybersecurity solutions, and space-related services. Major programs contributing to the company's revenues include the F-35 Lightning II fighter jet, the B-21 Raider bomber, missile defense systems, and various unmanned aerial vehicles (UAVs). Additionally, Northrop Grumman has established significant partnerships with other defense contractors, suppliers, and governmental agencies, which enhance its market position and contribute to its earnings. Factors such as increasing defense budgets, global security dynamics, and the demand for advanced technological solutions further support the company's revenue growth.

Northrop Grumman Key Performance Indicators (KPIs)

Any
Any
Revenue by Segment
Revenue by Segment
Breaks down sales across various divisions, showcasing which areas are growing and contributing most to the company's top line, indicating strategic strengths or weaknesses.
Chart InsightsNorthrop Grumman's Space Systems revenue, after years of growth, has sharply declined since late 2023, likely due to the B-21 program's cost issues and contracting delays. Meanwhile, Defense Systems revenue surged in late 2024, possibly benefiting from new contracts like the IBCS award. Despite a 7% drop in Q1 2025 sales, the company maintains confidence in achieving its full-year sales target, driven by strong international sales and a record backlog. Investors should watch for resolution of B-21 challenges and the impact of international growth on overall performance.
Data provided by:The Fly

Northrop Grumman Earnings Call Summary

Earnings Call Date:Oct 21, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:Jan 27, 2026
Earnings Call Sentiment Neutral
The earnings call reflects a generally positive outlook with strong performance in international sales, cash flow, and program milestones. However, there are concerns about revised revenue guidance and challenges in the space segment. The potential impact of the U.S. Government shutdown remains a concern.
Q3-2025 Updates
Positive Updates
Strong Book to Bill Ratio
Northrop Grumman achieved a book to bill ratio of 1.17 in the quarter, indicating strong demand and future business prospects.
International Growth
The company reported an international growth rate of 32% and year-to-date international sales growth of 20%.
Free Cash Flow Increase
Free cash flow increased by 72% year over year, reflecting strong operational performance.
Significant Program Milestones
The second B-21 aircraft entered flight test, and the company received a multibillion-dollar extension on the ground-based Midcourse Defense Weapon Systems contract.
Investment in Infrastructure and Technology
Over $2 billion invested in developing a digital ecosystem with high correlation to physical products, and $2.1 billion in IRAD for technology leadership.
Negative Updates
Revenue Guidance Revision
Full-year revenue guidance revised down due to delayed timing on certain awards and programs.
Space Segment Challenges
The space segment faced a challenging compare due to the wind down of two large programs, impacting revenue growth.
Impact of U.S. Government Shutdown
Potential delays in awards and funding due to the U.S. Government shutdown could impact financial results if prolonged.
Program Award Delays
Program award delays attributed to new administration transitions and recent government shutdown.
Company Guidance
In the third quarter of 2025, Northrop Grumman reported significant financial and operational achievements, with a 5% organic growth rate year over year and an impressive international growth rate of 32%. The company achieved a book-to-bill ratio of 1.17, reflecting robust demand. Despite a challenging compare in the space segment, overall revenue growth reached approximately 9%. The segment operating margin increased to 12.3%, driving a 10% year-over-year increase in earnings per share. Free cash flow surged by 72% year over year, aligning with their full-year guidance. Looking ahead, Northrop Grumman anticipates mid-single-digit organic sales growth in 2026, supported by growth in all four segments, and they maintain confidence in achieving a segment operating margin rate in the low to mid 11% range. Free cash flow for 2026 is projected between $3.1 billion and $3.5 billion, reflecting the company's continued focus on disciplined execution and long-term strategic growth.

Northrop Grumman Financial Statement Overview

Summary
Northrop Grumman exhibits strong financial health with robust profitability, improved leverage, and solid cash flow generation. The company has effectively managed its operations to maintain healthy margins and growth. While the reduction in leverage is a positive development, historical high debt levels and slight margin pressures should be monitored.
Income Statement
85
Very Positive
Northrop Grumman's income statement shows strong profitability with a consistent gross profit margin of around 20% and a net profit margin close to 10% in the TTM period. The company has maintained a positive revenue growth rate, albeit slightly lower than previous years, indicating steady demand. EBIT and EBITDA margins remain healthy, reflecting efficient operations. However, the slight decline in gross profit margin from the previous year suggests potential cost pressures.
Balance Sheet
78
Positive
The balance sheet reflects a solid financial position with a low debt-to-equity ratio of 0.23 in the TTM period, significantly improved from previous years, indicating reduced leverage. Return on equity remains robust at over 26%, showcasing effective use of equity capital. The equity ratio is stable, suggesting a balanced asset structure. However, the historical high leverage in previous years poses a potential risk if not managed carefully.
Cash Flow
82
Very Positive
Cash flow analysis reveals strong free cash flow growth of over 40% in the TTM period, highlighting improved cash generation capabilities. The operating cash flow to net income ratio is healthy, indicating efficient conversion of income to cash. The free cash flow to net income ratio is over 50%, demonstrating good cash profitability. Despite these strengths, the decline in operating cash flow from the previous year warrants attention.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue40.93B41.03B39.29B36.60B35.67B36.80B
Gross Profit7.95B8.36B6.55B7.47B7.27B7.48B
EBITDA7.01B6.84B4.23B7.68B8.73B5.59B
Net Income4.02B4.17B2.06B4.90B7.00B3.19B
Balance Sheet
Total Assets49.30B49.36B46.54B43.76B42.58B44.47B
Cash, Cash Equivalents and Short-Term Investments1.96B4.35B3.11B2.58B3.53B4.91B
Total Debt16.96B18.40B16.05B15.00B14.66B16.61B
Total Liabilities33.31B34.07B31.75B28.44B29.65B33.89B
Stockholders Equity15.99B15.29B14.79B15.31B12.93B10.58B
Cash Flow
Free Cash Flow1.83B2.62B2.10B1.47B2.15B2.88B
Operating Cash Flow3.44B4.39B3.88B2.90B3.57B4.30B
Investing Cash Flow-1.29B-1.75B-1.58B-1.24B2.06B-1.21B
Financing Cash Flow-3.52B-1.40B-1.76B-2.61B-7.00B-432.00M

Northrop Grumman Technical Analysis

Technical Analysis Sentiment
Positive
Last Price568.46
Price Trends
50DMA
573.63
Negative
100DMA
579.78
Negative
200DMA
537.52
Positive
Market Momentum
MACD
-1.03
Negative
RSI
53.00
Neutral
STOCH
60.91
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NOC, the sentiment is Positive. The current price of 568.46 is above the 20-day moving average (MA) of 560.17, below the 50-day MA of 573.63, and above the 200-day MA of 537.52, indicating a neutral trend. The MACD of -1.03 indicates Negative momentum. The RSI at 53.00 is Neutral, neither overbought nor oversold. The STOCH value of 60.91 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for NOC.

Northrop Grumman Risk Analysis

Northrop Grumman disclosed 21 risk factors in its most recent earnings report. Northrop Grumman reported the most risks in the "Production" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Northrop Grumman Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
80
Outperform
$91.67B21.9917.78%1.73%11.86%17.39%
76
Outperform
$81.13B20.4126.15%1.61%-0.14%72.35%
74
Outperform
$244.03B37.3710.49%1.47%8.79%39.63%
70
Outperform
$109.71B26.4762.78%2.84%2.88%-35.15%
70
Neutral
$53.77B30.879.13%1.67%2.83%47.00%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
54
Neutral
$167.64B-15.6410.19%-6.03%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
NOC
Northrop Grumman
568.46
106.94
23.17%
BA
Boeing
214.08
36.73
20.71%
GD
General Dynamics
339.36
81.03
31.37%
LHX
L3Harris Technologies
287.45
77.04
36.61%
LMT
Lockheed Martin
474.13
-0.89
-0.19%
RTX
RTX
182.01
67.66
59.17%

Northrop Grumman Corporate Events

Executive/Board ChangesBusiness Operations and Strategy
Northrop Grumman Appoints New CFO John Greene
Positive
Nov 6, 2025

On November 6, 2025, Northrop Grumman Corporation announced the election of John Greene as the new corporate vice president and chief financial officer, effective January 7, 2026. Greene, who has a distinguished record in finance leadership across various industries, will succeed Kenneth Crews, who will step down but remain in an advisory role until February 20, 2026. The company reaffirmed its 2025 financial guidance and 2026 outlook, emphasizing the strategic importance of this leadership transition in navigating a dynamic market with significant growth opportunities.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 09, 2025